Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetics and Pharmacodynamics Study of Piperacillin/Tazobactam During Early Phase in Critically Ill Patients With Severe Sepsis

NCT02730624 is registered in ClinicalTrials.gov with Sutep Jaruratanasirikul as lead sponsor.

NCT NCT02730624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02730624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetics and Pharmacodynamics Study of Piperacillin/Tazobactam During Early Phase in Critically Ill Patients With Severe Sepsis
Lead sponsor
Sutep Jaruratanasirikul
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
January 31, 2017
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early phase of severe sepsis and septic shock